Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 28: | Line 28: | ||
! colspan="2" rowspan="5" |Diseases | ! colspan="2" rowspan="5" |Diseases | ||
| colspan="12" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="12" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
| | |||
! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
Line 34: | Line 35: | ||
| colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
! | |||
|- | |- | ||
! | |||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
Line 50: | Line 53: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Wheezing | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Wheezing | ||
! rowspan="2" | '''Tricuspid regurgitation murmur''' | ! rowspan="2" | '''Tricuspid regurgitation murmur''' | ||
! | |||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Urinary 5-hydroxyindoleacetic acid (5-HIAA)''' | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Urinary 5-hydroxyindoleacetic acid (5-HIAA)''' | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Serum Chromogranin A (CgA)''' | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Serum Chromogranin A (CgA)''' | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
Line 60: | Line 64: | ||
!Diarrhea | !Diarrhea | ||
!Constipation | !Constipation | ||
! | |||
|- | |- | ||
| rowspan="3" |Appendix cancer | | rowspan="3" |Appendix cancer | ||
Line 74: | Line 79: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 98: | Line 104: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 122: | Line 129: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 135: | Line 143: | ||
|- | |- | ||
| colspan="2" |Mucocele | | colspan="2" |Mucocele | ||
| | |||
| | | | ||
| | | | ||
Line 159: | Line 168: | ||
|- | |- | ||
| colspan="2" |Ovarian tumor | | colspan="2" |Ovarian tumor | ||
| | |||
| | | | ||
| | | | ||
Line 183: | Line 193: | ||
|- | |- | ||
| colspan="2" |Pseudomyxoma peritonei | | colspan="2" |Pseudomyxoma peritonei | ||
| | |||
| | | | ||
| | | | ||
Line 207: | Line 218: | ||
|- | |- | ||
| colspan="2" |Carcinoid syndrome | | colspan="2" |Carcinoid syndrome | ||
| | |||
| | | | ||
| | | | ||
Line 231: | Line 243: | ||
|- | |- | ||
| colspan="2" |Appendicitis | | colspan="2" |Appendicitis | ||
|LLQ / RRQ | |||
| | | | ||
| | | | ||
|<nowiki>+</nowiki> | |||
| | | | ||
| | | | ||
| | | | ||
|[[Nausea and vomiting|Nausea & vomiting]],[[decreased appetite]] | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|'''Rebound tenderness, Guarding,''' | |||
| | | | ||
| | | | ||
| | | | ||
* [[Leukocytosis]] | |||
* Left shift | |||
| | | | ||
| | | | ||
| | |Evidences of [[inflammation]] | ||
| | | | ||
| | | | ||
Line 267: | Line 282: | ||
! colspan="1" rowspan="1" |Physical exam 2 | ! colspan="1" rowspan="1" |Physical exam 2 | ||
!Physical exam 3 | !Physical exam 3 | ||
! | |||
! | ! | ||
!Lab 1 | !Lab 1 | ||
Line 292: | Line 308: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 317: | Line 334: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 342: | Line 360: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| | | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 17:54, 8 February 2019
Appendix cancer Microchapters |
Diagnosis |
---|
Treatment |
Appendix cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Appendix cancer differential diagnosis |
Risk calculators and risk factors for Appendix cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
appendix cancer must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
appendix cancer must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating appendix cancer from other Diseases
appendix cancer must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
appendix cancer must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating appendix cancer from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], appendix cancer must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||||||||||
Lab Findings | Imaging | Histopathology | ||||||||||||||||||||||
Abdominal pain | Change in girdle size | Change in bowel habits | Flushing | Palpitation | Dyspnea | Other symptoms | Abdominal mass | abdominal tenderness | Wheezing | Tricuspid regurgitation murmur | Urinary 5-hydroxyindoleacetic acid (5-HIAA) | Serum Chromogranin A (CgA) | Other lab findings | CT scan | MRI | Utrasounography | Other imaging modalities | |||||||
Diarrhea | Constipation | |||||||||||||||||||||||
Appendix cancer | Adenocarcinoma | |||||||||||||||||||||||
Carcinoid tumor | ||||||||||||||||||||||||
Mucocele | ||||||||||||||||||||||||
Ovarian tumor | ||||||||||||||||||||||||
Pseudomyxoma peritonei | ||||||||||||||||||||||||
Carcinoid syndrome | ||||||||||||||||||||||||
Appendicitis | LLQ / RRQ | + | Nausea & vomiting,decreased appetite | Rebound tenderness, Guarding, |
|
Evidences of inflammation | ||||||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings | |||||||||
Differential Diagnosis 4 | ||||||||||||||||||||||||
Differential Diagnosis 5 | ||||||||||||||||||||||||
Differential Diagnosis 6 |